首页> 外文期刊>Biomarkers in Cancer >Tissue Factor–Factor VII Complex as a Key Regulator of Ovarian Cancer Phenotypes:
【24h】

Tissue Factor–Factor VII Complex as a Key Regulator of Ovarian Cancer Phenotypes:

机译:组织因子-因子VII复合物是卵巢癌表型的关键调节因子:

获取原文
       

摘要

Tissue factor (TF) is an integral membrane protein widely expressed in normal human cells. Blood coagulation factor VII (fVII) is a key enzyme in the extrinsic coagulation cascade that is predominantly secreted by hepatocytes and released into the bloodstream. The TF–fVII complex is aberrantly expressed on the surface of cancer cells, including ovarian cancer cells. This procoagulant complex can initiate intracellular signaling mechanisms, resulting in malignant phenotypes. Cancer tissues are chronically exposed to hypoxia. TF and fVII can be induced in response to hypoxia in ovarian cancer cells at the gene expression level, leading to the autonomous production of the TF–fVII complex. Here, we discuss the roles of the TF–fVII complex in the induction of malignant phenotypes in ovarian cancer cells. The hypoxic nature of ovarian cancer tissues and the roles of TF expression in endometriosis are discussed. Arguments will be extended to potential strategies to treat ovarian cancers based on our current knowledge of TF–fVII function.
机译:组织因子(TF)是在正常人细胞中广泛表达的不可或缺的膜蛋白。凝血因子VII(fVII)是外在凝血级联中的关键酶,主要由肝细胞分泌并释放到血流中。 TF-fVII复合物在包括卵巢癌细胞在内的癌细胞表面异常表达。这种促凝血复合物可以启动细胞内信号传导机制,导致恶性表型。癌症组织长期处于缺氧状态。 TF和fVII可以在基因表达水平上响应卵巢癌细胞的低氧反应,从而导致TF-fVII复合物的自主生产。在这里,我们讨论了TF-fVII复合体在卵巢癌细胞恶性表型诱导中的作用。讨论了卵巢癌组织的缺氧性以及TF表达在子宫内膜异位症中的作用。基于我们目前对TF-fVII功能的了解,争论将扩展到治疗卵巢癌的潜在策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号